Propanc Biopharma issues $82,500 promissory note to accredited investor

Propanc Biopharma, Inc.

Principal amount $82,500; purchase price $75,000; 10% annual interest.
Maturity date September 15, 2025; proceeds used for general working capital.
Repayment: 100% of principal if repaid by Aug 18, 2025; 120% if after Aug 18 up to Sept 18, 2025.
Note issued under private placement exemption Rule 506/Reg D; no equity securities sold.

item 1.01item 2.03item 3.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.